Petr Svoboda

Summary

Country: Czech Republic

Publications

  1. ncbi Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?
    Petr Svoboda
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Brno
    Hepatogastroenterology 54:359-63. 2007
  2. doi Terlipressin in the treatment of late phase catecholamine-resistant septic shock
    Petr Svoboda
    Trauma Hospital Brno, Research Center for Traumatology and Surgery, Brno, Czech Republic
    Hepatogastroenterology 59:1043-7. 2012
  3. pmc The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Haleema Shakur
    Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Trials 10:109. 2009
  4. ncbi [CRASH--the first large randomized controlled study of head injuries]
    P Svoboda
    University of London, CRASH Co ordinating Center, UK
    Rozhl Chir 80:453-5. 2001
  5. ncbi Helicobacter pylori is not a risk factor for stress ulcer bleeding in polytraumatized patients
    Petr Svoboda
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Brno, Czech Republic
    Hepatogastroenterology 51:476-80. 2004
  6. doi Our experience with transoral incisionless plication of gastroesophageal reflux disease: NOTES procedure
    Petr Svoboda
    Trauma Hospital, Brno, Czech Republic
    Hepatogastroenterology 58:1208-13. 2011
  7. ncbi Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial
    Ilona Kantorova
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Czech Republic
    Hepatogastroenterology 51:757-61. 2004
  8. ncbi Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial
    Martin Dolecek
    Trauma Hospital Brno, Czech Republic
    Hepatogastroenterology 56:1622-8. 2009

Collaborators

  • I G Roberts
  • Ilona Kantorova
  • Haleema Shakur
  • Martin Dolecek
  • Peter Scheer
  • Patrick Druwé
  • Cristian Boeriu
  • Martin Radvan
  • Bennie Hartzenberg
  • Chris Frost
  • Indrek Ratsep
  • Jitka Bíbrová
  • Jorge Mejia Mantilla
  • Laura Balica
  • Ramalingam R Ravi
  • Olivia Fletcher
  • Yashbir Dewan
  • Cristina Sampaio
  • Toomas Asser
  • Peter Andrews
  • Igor Sas
  • Francisco Murillo-Cabezas
  • Jan Pachl
  • Manmohan Singh
  • Jana Radvanova
  • Juan Diego Ciro Quintero
  • Jiri Ochmann
  • Dagmar Rehorkova
  • Jaroslav Doubek
  • Hana Bosakova

Detail Information

Publications8

  1. ncbi Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?
    Petr Svoboda
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Brno
    Hepatogastroenterology 54:359-63. 2007
    ..The discrimination between local and generalized infection is critical for correct treatment...
  2. doi Terlipressin in the treatment of late phase catecholamine-resistant septic shock
    Petr Svoboda
    Trauma Hospital Brno, Research Center for Traumatology and Surgery, Brno, Czech Republic
    Hepatogastroenterology 59:1043-7. 2012
    ..In this situation, addition of vasopressin or terlipressin can be advantageous. The aim of our pilot study was to evaluate the impact of terlipressin on open label norepinephrine requirements and mortality...
  3. pmc The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
    Haleema Shakur
    Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
    Trials 10:109. 2009
    ..We evaluated the safety and effectiveness of the non-peptide bradykinin B2 receptor antagonist Anatibant in the treatment of patients with traumatic brain injury. During the course of the trial, funding was withdrawn by the sponsor...
  4. ncbi [CRASH--the first large randomized controlled study of head injuries]
    P Svoboda
    University of London, CRASH Co ordinating Center, UK
    Rozhl Chir 80:453-5. 2001
    ..This calls for unselfish cooperation of physicians and nurses world-wide. In the Czech Republic so far six departments participate in the study and we would be glad if this number would increase substantially...
  5. ncbi Helicobacter pylori is not a risk factor for stress ulcer bleeding in polytraumatized patients
    Petr Svoboda
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Brno, Czech Republic
    Hepatogastroenterology 51:476-80. 2004
    ..The aim of our study was to evaluate the relationship between Helicobacter pylori serological status of patients developing stress-related bleeding and those with no appearance of upper gastrointestinal bleeding...
  6. doi Our experience with transoral incisionless plication of gastroesophageal reflux disease: NOTES procedure
    Petr Svoboda
    Trauma Hospital, Brno, Czech Republic
    Hepatogastroenterology 58:1208-13. 2011
    ..Gastroesophageal reflux disease (GERD) appears to be the most promising application of NOTES treatment. The aims of our study were to evaluate the safety and efficacy of this procedure and length of hospital stay...
  7. ncbi Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial
    Ilona Kantorova
    Traumatological Hospital Brno, Research Center for Traumatology and Surgery, Czech Republic
    Hepatogastroenterology 51:757-61. 2004
    ..There are conflicting data on the efficacy and complication rates of various prophylactic regimens...
  8. ncbi Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial
    Martin Dolecek
    Trauma Hospital Brno, Czech Republic
    Hepatogastroenterology 56:1622-8. 2009
    ....